Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Owlstone Medical Enters Partnership with Bicycle Therapeutics for the Development of Antigen-Targeted EVOC Probes for Early Cancer Detection
, /in E-News /by panglobalResearch will focus on applying Bicycle’s bicyclic peptide technology to Owlstone’s EVOC Probes Antigen-targeted EVOC Probes have potential for use in preclinical research, clinical trials, and as companion diagnostics and tests for early detection of disease Initial research will focus on the early detection of lung cancer
Cantargia treats first triple-negative breast cancer patient in randomized phase II part of TRIFOUR trial
, /in E-News /by panglobalCantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today reported that, following positive results in the lead-in phase of the clinical phase Ib/II trial TRIFOUR, the first triple-negative breast cancer (TNBC) patient has initiated treatment with the IL1RAP-binding antibody nadunolimab (CAN04) and chemotherapy in the phase II randomized part of the trial. Up to 98 patients may […]
Neogap and Simsen Diagnostics enter collaboration to improve personalised cancer diagnostics
, /in E-News /by panglobalThe biotechnology company Neogap and the cancer diagnostics company Simsen Diagnostics have initiated a collaboration aimed at improving personalised cancer diagnostics by examining circulating tumor DNA in the blood of patients participating in Neogap’s phase I/II clinical trial. The goal is to develop more precise and effective diagnostic tools for cancer.
Siemens Healthineers and Sysmex establish global agreement to supply hemostasis instruments, reagents as OEMs
, /in E-News /by panglobalBuilding on a 25+ year partnership, the companies will each provide one of the largest hemostasis testing system and reagent portfolios to laboratories. Under the multi-year agreement, both companies will individually distribute their combined portfolio of hemostasis instruments and reagents worldwide under their respective own brands.
Nipping allergies in the bud with the PIPETBOY from INTEGRA Biosciences
, /in E-News /by panglobalResearchers at Uppsala University in Sweden are using INTEGRA Biosciences’ PIPETBOY pro pipette controllers with integrated LED lighting to study the physiological function of mast cells and their role in allergic reactions. Their ultimate aim is to develop novel vaccines and therapies to prevent and treat common allergies.
EVOSEP ESTABLISHES CENTER OF EXCELLENCE FOR HIGH-THROUGHPUT AND STANDARDIZED PROTEOMICS
, /in E-News /by panglobalMaking clinical proteomics 100x more robust and 10x faster Evosep aims to improve quality of life and patient care by radically innovating protein based clinical diagnostics. We will make sample preparation and separation for MS analysis 10 times faster and 100 times more robust in order to enable truly large cohort studies and provide […]
Greiner Bio-One donates products to Ukraine again
, /in E-News /by panglobalUkraine continues to need humanitarian aid as a result of the ongoing war. As a manufacturer of laboratory and medical products, Greiner Bio-One is following a request for assistance from the European Commission and is again making product donations worth a total of €26,000.
Ziath launches DP5 Mobile enabling remote control of tube barcode readers and scanners
, /in Product News /by panglobalZiath has launched a new version of their popular DP5 Network application that enables tube barcode readers and scanners to be remote controlled from a smart phone or tablet via a Wi-Fi connection.
65 Years of stem cell transplantation: insights into improvements and current challenges
, /in E-News /by panglobalBy Dr Andreas Boehmler Accounting for nearly 10% of all cancer diagnoses, blood cancers remain a threat to people of all ages. Since the first successful transplant in 1956, stem cell transplantation has become prevalent in leukemia treatment. Today, quantitative measures of stem cell transplants, such as enumeration of viable CD34-positive hematopoietic stem cells, inform the […]
Roche joins forces with the U.S. Centers for Disease Control and Prevention to strengthen laboratory systems in the fight against the HIV and tuberculosis epidemics
, /in E-News /by panglobalIt is critical to strengthen laboratories to enable more people to access quality testing and build stronger, resilient healthcare systems Public-private partnerships contribute to strengthening laboratory systems by leveraging the respective strengths, experience, and resources of the partners About 2 billion people worldwide are estimated to be infected with tuberculosis and more than 38 million […]